Filter
2298
Filtered Results: 2298
Text search:
M.
Kan
Featured
Recommendations
198
New Publications
542
Language
Document type
No document type
1302
Studies & Reports
401
Guidelines
325
Manuals
102
Strategic & Response Plan
48
Fact sheets
47
Training Material
36
Brochures
15
Situation Updates
12
Resource Platforms
6
Infographics
3
Videos
1
Countries / Regions
Germany
196
India
107
Indonesia
73
Nigeria
62
Global
62
Kenya
61
Western and Central Europe
54
Nepal
48
Malawi
41
South Africa
34
Congo, Democratic Republic of
33
Sierra Leone
32
Africa
31
Bangladesh
29
Russia
29
Zambia
29
Uganda
28
Senegal
26
Ethiopia
26
Myanmar / Burma
24
Eastern Europe
23
Latin America and the Carribbean
21
Rwanda
20
Tanzania
20
Ukraine
17
Cambodia
17
Haiti
16
West and Central Africa
16
Brazil
16
Zimbabwe
15
Liberia
14
Ghana
12
Syria
12
Burkina Faso
12
Asia
12
Middle East and North Africa
12
Benin
11
Guinea
11
Mozambique
11
South–East Asia Region
11
Botswana
10
Colombia
9
Cameroon
9
Philippines
9
East and Southern Africa
9
Argentina
9
Mali
9
Afghanistan
8
Peru
8
Niger
7
Venezuela
7
Namibia
7
Yemen
7
South Sudan
7
Tajikistan
6
Eastern Europe and Central Asia
6
Thailand
5
China
5
USA
5
Paraguay
5
Spain
5
Sudan
5
Angola
5
Ecuador
5
Lesotho
4
Canada
4
Bolivia
4
Vietnam
4
Chad
4
Pakistan
4
Switzerland
3
El Salvador
3
Turkey
3
Albania
3
Guinea-Bissau
3
North America
3
Lebanon
3
Sri Lanka
3
Somalia
3
Eswatini/ Swaziland
3
Guatemala
3
Mexico
2
Kazakhstan
2
Chile
2
Laos
2
Estonia
2
Morocco
2
Italy
2
Jordan
2
Saudi Arabia
2
France
2
Tunisia
2
United Kingdom
2
Côte d’Ivoire / Ivory Coast
2
Papua New Guinea
2
Central African Republic
2
Iraq
2
Madagascar
2
Timor Leste/ East Timor
1
Gambia
1
Togo
1
Iran
1
Kyrgyzstan
1
Congo-Brazzaville
1
Malaysia
1
Austria
1
Mongolia
1
Qatar
1
Mauritania
1
Dominican Republic
1
Western Pacific Region
1
Uruguay
1
Portugal
1
Belarus
1
Israel
1
Southern Africa
1
Nicaragua
1
Egypt
1
Romania
1
Greece
1
Palestine
1
Georgia
1
Honduras
1
Libya
1
Solomon Islands
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
843
Clinical Guidelines
163
Public Health
97
Women & Child Health
91
Key Resources
50
Capacity Building
22
Pharmacy & Technologies
13
Toolboxes
TB
263
Mental Health
202
COVID-19
194
Refugee
179
HIV
135
Planetary Health
95
Caregiver
74
Disability
62
NTDs
57
AMR
55
Ebola
52
Global Health Education
50
Rapid Response
39
NCDs
39
Pharmacy
37
Conflict
19
Natural Hazards
18
Cholera
17
Polio
10
Zika
8
Specific Hazards
7
Health Financing Toolbox
7
Social Ethics
4
À l’ère des évolutions numérique, démocratique, sociétale et politique, la communication est devenue plus que jamais une passerelle d’idées et d’initiatives révolutionnaires, capable de créer des communautés plus fortes, plus informées et plus impliquées que jamais. L’émergence ...
En la era del cambio digital, democrático, social y político, la comunicación se ha convertido en un medio esencial para expresar ideas y desarrollar iniciativas revolucionarias, capaces de crear comunidades más fuertes, mejor informadas y más comprometidas que nunca. El surgimiento del periodi...
The Practical manual on laboratory strengthening, 2022 update provides practical guidance on implementation of WHO recommendations and best practices for TB laboratory strengthening. It is an updated version of the GLI Practical Guide to Laboratory Strengthening published in 2017 and provides the la...
Le secteur de la santé a beaucoup évolué au cours des 20 dernières années. Les innovations technologiques ainsi que notre connaissance des maladies ont contribué à allonger l’espérance de vie au 20ème siècle. Cependant, l’un des plus grands défis
aujourd’hui n’est pas de rester a...
Report of the WHO/Bill & Melinda Gates Foundation Consultation. The Consultation was organized back-to-back with the first annual meeting of the International Coordinating Group of the BMGF-funded project for human and dog rabies elimination in developing countries, held at WHO headquarters, Geneva,...
L’objectif de ces lignes directrices est de présenter l’ensemble complet des recommandations et des énoncés de meilleures pratiques de l’OMS en matière d’avortement
This document provides an overview of strategic purchasing of nutrition services within primary health care. It introduces key terms and payment methods for countries to use in preparing to transform their health financial systems to scale up nutrition services. It does so by introducing nutritional...
Human African trypanosomiasis (HAT) has been an alarming global public health issue. The disease affects mainly poor and marginalized people in low-resource settings and is caused by two subspecies of haemoflagellate parasite, Trypanosoma brucei and transmitted by tsetse flies. Progress made in HAT ...
Gambiense human African trypanosomiasis is a deadly infectious disease affecting West and Central Africa, South Sudan and Uganda, and transmitted between humans by tsetse flies. The disease has caused several major epidemics, the latest one in the 1990s. Thanks to recent innovations such as rapid di...
Mali national action plan on antimicrobial resistance: review of progress in the human health sector
This policy brief aims to provide a review of the current progress on implementing the Mali national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing act...
An interregional meeting on leishmaniasis among neighbouring endemic
countries in the Eastern Mediterranean, African and European regions was organized by the World Health Organization (WHO) Regional Office for the Eastern
Mediterranean in Amman, Jordan, from 23 to 25 September 2018. The meeting w...
Chromoblastomycosis (CMB) is a chronic fungal infection of the skin and the subcutaneous tissue caused by a transcutaneous traumatic inoculation of a specific group of dematiaceous fungi occurring mainly in tropical and subtropical zones worldwide. If not diagnosed at early stages, patients with CBM...
The objectives of the meeting were:
1. To step up the commitment of national authorities and technical and financial partners toWHO’s elimination objective for g-HAT.
2. To share achievements, challenges and views on the elimination goal among countries and implementing partners.
3. To assess t...
Snakebite envenoming affects millions of people worldwide annually and is a significant source of mortality. Preventing and treating the problem is complex and requires collaboration among the fields of public health, medicine, ecology, and laboratory science. After being removed from the category A...
The major neglected tropical diseases, Taenia solium taeniosis/cysticercosis and schistosomiasis caused by Schistosoma mansoni or S. haematobium are presumed to be widely distributed in Africa. Taenia solium taeniosis/ cysticercosis has been reported as an emerging disease in different regions of Af...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of the COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly re...
The epidemiology of the disease is mediated by the interaction of the parasite (trypanosome) with the vectors (tsetse flies), as well as with the human and animal hosts within a particular environment. Related to these interactions, the disease is confined in spatially limited areas called “foci...
Human rabies remains a significant public health problem in Africa with outbreaks reported in most countries. In Nigeria–the most populous country in Africa–rabies causes a significant public health burden partly due to perennial obstacles to implementing a national prevention and control progra...
Rabies has an enormous impact on both agriculture and conservation biology, but its greatest burden is undeniably on public health. As such, routine methods for rapid risk assessment after human exposures to rabies as well as applications for laboratory-based surveillance, production of biologicals ...
Avec l’essor des traitements antirétroviraux (TAR) à base de dolutégravir (DTG) pour soigner les personnes vivant avec
le VIH dans le monde, il est important d’estimer la vitesse à laquelle la résistance acquise au DTG apparaît dans les
populations sous TAR. Bien que la résistance au DT...
